Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The EMBO Journal|October 2, 1998
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liverD Maione, E Di Carlo, W Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytesM Giovarelli, P Cappello, G Forni, et al.
Cell Death & Disease|December 11, 2012
Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cellsV Folgiero, S E Di Carlo, G Bon, et al.
Plos One|February 14, 2008
Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomasValentina Folgiero, Paolo Avetrani, Giulia Bon, et al.
The Journal of Experimental Medicine|November 7, 2001
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceP Nanni, G Nicoletti, C De Giovanni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c miceS Rovero, A Amici, E Di Carlo, et al.
International Journal of Cancer|June 22, 2000
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaP Nanni, S M Pupa, G Nicoletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactionsM Giovarelli, P Musiani, G Garotta, et al.
The Journal of Experimental Medicine|August 4, 1998
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.
Pageof 5